The estimated Net Worth of Alexander E Barkas is at least $244 Thousand dollars as of 5 June 2007. Alexander Barkas owns over 6,427 units of Geron stock worth over $147,539 and over the last 21 years Alexander sold GERN stock worth over $96,405.
Alexander has made over 1 trades of the Geron stock since 2007, according to the Form 4 filled with the SEC. Most recently Alexander sold 6,427 units of GERN stock worth $96,405 on 5 June 2007.
The largest trade Alexander's ever made was selling 6,427 units of Geron stock on 5 June 2007 worth over $96,405. On average, Alexander trades about 321 units every 0 days since 2003. As of 5 June 2007 Alexander still owns at least 33,608 units of Geron stock.
You can see the complete history of Alexander Barkas stock trades at the bottom of the page.
Alexander's mailing address filed with the SEC is C/O PROSPECT VENTURE PARTNERS, 435 TASSO STREET, SUITE 200, PALO ALTO, CA, 94301.
Over the last 21 years, insiders at Geron have traded over $2,393,273 worth of Geron stock and bought 340,678 units worth $567,384 . The most active insiders traders include John A Scarlett, Daniel Bradbury, and Stephen Rosenfield. On average, Geron executives and independent directors trade stock every 93 days with the average trade being worth of $587,812. The most recent stock trade was executed by Andrew J Grethlein on 8 July 2024, trading 674,348 units of GERN stock currently worth $1,159,879.
we are a biopharmaceutical company developing first-in-class therapies for cancer. imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. imetelstat is a potent and specific inhibitor of telomerase. based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or mf, myelodysplastic syndromes, or acute myelogenous leukemia.
Geron executives and other stock owners filed with the SEC include: